scispace - formally typeset
Open AccessJournal ArticleDOI

Brain Volumes in Schizophrenia: A Meta-Analysis in Over 18 000 Subjects

Reads0
Chats0
TLDR
Brain loss in schizophrenia is related to a combination of (early) neurodevelopmental processes-reflected in intracranial volume reduction-as well as illness progression.
Abstract
Although structural brain alterations in schizophrenia have been demonstrated extensively, their quantitative distribution has not been studied over the last 14 years despite advances in neuroimaging. Moreover, a volumetric meta-analysis has not been conducted in antipsychotic-naive patients. Therefore, meta-analysis on cross-sectional volumetric brain alterations in both medicated and antipsychotic-naive patients was conducted. Three hundred seventeen studies published from September 1, 1998 to January 1, 2012 comprising over 9000 patients were selected for meta-analysis, including 33 studies in antipsychotic-naive patients. In addition to effect sizes, potential modifying factors such as duration of illness, sex composition, current antipsychotic dose, and intelligence quotient matching status of participants were extracted where available. In the sample of medicated schizophrenia patients (n = 8327), intracranial and total brain volume was significantly decreased by 2.0% (effect size d = -0.17) and 2.6% (d = -0.30), respectively. Largest effect sizes were observed for gray matter structures, with effect sizes ranging from -0.22 to -0.58. In the sample of antipsychotic-naive patients (n = 771), volume reductions in caudate nucleus (d = -0.38) and thalamus (d = -0.68) were more pronounced than in medicated patients. White matter volume was decreased to a similar extent in both groups, while gray matter loss was less extensive in antipsychotic-naive patients. Gray matter reduction was associated with longer duration of illness and higher dose of antipsychotic medication at time of scanning. Therefore, brain loss in schizophrenia is related to a combination of (early) neurodevelopmental processes-reflected in intracranial volume reduction-as well as illness progression.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Efficacy and safety of adjunctive therapy with fingolimod in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial

TL;DR: In this article , the efficacy and safety of fingolimod adjuvant to risperidone in schizophrenia treatment were investigated, and the positive and negative symptom scale was used to measure and compare the effectiveness of treatment strategies at baseline and weeks 2, 4, 6, and 8.
Journal ArticleDOI

Retroverting schizophrenia

TL;DR: This article proposed that if a categorical diagnosis of schizophrenia makes sense, points of rarity should be observable in causal risk factors, genetic or environmental, and/or the neural systems on which they impact.
Journal ArticleDOI

Large-Scale Thalamocortical Triple Network Dysconnectivities in Patients With First-Episode Psychosis and Individuals at Risk for Psychosis.

TL;DR: In this article , the authors used modular community detection to identify cortical and thalamic resting-state networks, and thalamocortical network interactions were compared across the groups.
Posted Content

Brain tissue fingerprints of schizophrenia and control individuals

TL;DR: In this paper, the authors found geometric fingerprints of schizophrenia and control individuals by analyzing three-dimensional structures of cerebral tissues of the anterior cingulate cortex, and suggested that the structural difference identified in the cerebral tissue represents our mental diversity.
References
More filters
Book

Statistical Power Analysis for the Behavioral Sciences

TL;DR: The concepts of power analysis are discussed in this paper, where Chi-square Tests for Goodness of Fit and Contingency Tables, t-Test for Means, and Sign Test are used.
Journal ArticleDOI

Measuring inconsistency in meta-analyses

TL;DR: A new quantity is developed, I 2, which the authors believe gives a better measure of the consistency between trials in a meta-analysis, which is susceptible to the number of trials included in the meta- analysis.
Journal ArticleDOI

Meta-Analysis of Regional Brain Volumes in Schizophrenia

TL;DR: In this article, the authors conducted a systematic search for structural magnetic resonance imaging (MRI) studies of patients with schizophrenia that reported volume measurements of selected cortical, subcortical, and ventricular regions in relation to comparison groups.
Journal ArticleDOI

Cerebral ventricular size and cognitive impairment in chronic schizophrenia

TL;DR: By comparison with age-matched controls in employment, 17 institutionalised schizophrenic patients were shown by computerised axial tomography of the brain to have increased cerebral ventricular size.
Journal ArticleDOI

Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers

TL;DR: In this article, the authors quantitatively quantitate neuroanatomic parameters in healthy volunteers and compare the values with normative values from postmortem studies, using MRI images of 116 volunteers aged 19 months to 80 years.
Related Papers (5)

Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium

T.G.M. van Erp, +66 more
- 01 Apr 2016 - 

Biological insights from 108 schizophrenia-associated genetic loci

Stephan Ripke, +354 more
- 24 Jul 2014 -